Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.10.887811113517.7183
Domestic EquitiesMax Healthcare Institute Ltd.6.16889005810.0388
Domestic EquitiesCipla Ltd.6.0484654759.8429
Domestic EquitiesApollo Hospitals Enterprise Ltd.5.3063116558.6352
Domestic EquitiesDr. Reddy's Laboratories Ltd.5.0868676478.2780
Domestic EquitiesDivi's Laboratories Ltd.4.8362138337.8703
Domestic EquitiesFortis Healthcare Ltd.3.3864568255.5109
Domestic EquitiesLupin Ltd.3.1057264435.0541
Domestic EquitiesTorrent Pharmaceuticals Ltd.3.0371137174.9425
Domestic EquitiesMankind Pharma Ltd.2.1460143383.4923
Domestic EquitiesLaurus Labs Ltd.2.1008406133.4188
Domestic EquitiesAurobindo Pharma Ltd.2.0158302653.2804
Domestic EquitiesGlenmark Pharmaceuticals Ltd.1.9605163393.1905
Domestic EquitiesZydus Lifesciences Ltd.1.7576291302.8603
Domestic EquitiesAlkem Laboratories Ltd.1.615548462.6290
Domestic EquitiesIPCA Laboratories Ltd.1.3295161582.1636
Domestic EquitiesBiocon Ltd.1.2976619272.1117
Domestic EquitiesGland Pharma Ltd.1.050785851.7098
Domestic EquitiesNarayana Hrudayalaya ltd.0.884482831.4393
Domestic EquitiesPiramal Pharma Ltd.0.8137692661.3241
Domestic EquitiesSyngene International Ltd.0.8036209971.3078
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Ltd.0.801549041.3043
Domestic EquitiesGlobal Health Ltd.0.753493311.2261
Domestic EquitiesAjanta Pharma Ltd.0.748650631.2183
Domestic EquitiesCohance Lifesciences Ltd.0.7179132901.1683
Total 68.6608 111.7356
Cash & Cash Equivalents and Net AssetsNet Receivables/(Payables)0.1417 0.2306
Cash & Cash Equivalents and Net AssetsClearing Corporation of India Ltd.0.1106 0.1800
Cash & Cash Equivalents and Net AssetsAccrued Interest0.0000 0.0000
Total 0.2523 0.4106
Overseas EquitiesELI LILLY & CO5.245512608.5363
Overseas EquitiesJOHNSON & JOHNSON3.804037606.1904
Overseas EquitiesABBVIE INC3.488127615.6763
Overseas EquitiesNOVARTIS AG2.078829713.3830
Overseas EquitiesABBOTT LABORATORIES1.987127193.2337
Overseas EquitiesMERCK & CO.INC1.797039242.9243
Overseas EquitiesTHERMO FISHER SCIENTIFIC INC1.56405912.5452
Overseas EquitiesNovo Nordisk A/S1.516050072.4670
Overseas EquitiesINTUITIVE SURGICAL INC1.36905612.2278
Overseas EquitiesAMGEN INC1.29498412.1073
Overseas EquitiesGILEAD SCIENCES INC1.178019451.9170
Overseas EquitiesDANAHER CORP1.089310071.7727
Overseas EquitiesSTRYKER CORP1.08515381.7659
Overseas EquitiesMEDTRONIC PLC1.040920031.6939
Overseas EquitiesVERTEX PHARMACEUTICALS INC0.85904021.3979
Overseas EquitiesRegeneron Pharmaceuticals Inc0.51241670.8338
Overseas EquitiesBECTON DICKINSON AND CO0.45754480.7445
Overseas EquitiesAGILENT TECHNOLOGIES INC0.31164450.5071
Overseas EquitiesIQVIA HOLDINGS INC0.28082710.4570
Overseas EquitiesILLUMINA INC0.12802470.2083
Total 31.0869 50.5894
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.